It is debated if omega-3 polyunsaturated fatty acids (N3PUFa) may be effective in preventing AF (atrial fibrillation), meta-analysis here.

However, much less has been considered this: Do N3-PUFAs prevent acute symptoms of periodic Atrial fibrillation?

The meta-analysis concentrate only in the long-term effects of prevention. My proposal focuses on the short-term i.e. the fact that the user can recognise AF first and then uses N3-PUFAs.

Please, assume that there is a validation method by which the user can easily detect that he has AF - he does this if he suspect it, i.e. feels special discomfort and special wave-like-pain the chest.

He takes each time in this case 20 ml of Müller omega-3 oil which has also vitamin D. The effect of recovering is immediate in prophylaxis. Assume the user has less than < 20 ng/ml vitamin D in blood each case, most of the time, 9 ng/ml so avitaminosis.

My conjuncture is that N3-PUFAs can prevent the acute symptoms of periodic AF.

How can N3-PUFAs prevent the acute symptoms of periodic AF? What is the role of vitamin D here?

It is debated if omega-3 polyunsaturated fatty acids (N3PUFa) may be effective in preventing AF (atrial fibrillation), meta-analysis here.

However, much less has been considered this: Do N3-PUFAs prevent acute symptoms of periodic Atrial fibrillation?

The meta-analysis concentrate only in the long-term effects of prevention. My proposal focuses on the short-term i.e. the fact that the user can recognise AF first and then uses N3-PUFAs.

Please, assume that there is a validation method by which the user can easily detect that he has AF - he does this if he suspect it, i.e. feels special discomfort and special wave-like-pain the chest.

He takes each time in this case 20 ml of Müller omega-3 oil which has also vitamin D. The effect of recovering is immediate in prophylaxis. Assume the user has less than < 20 ng/ml vitamin D in blood each case, most of the time, 9 ng/ml so avitaminosis.

My conjecture is that N3-PUFAs can prevent the acute symptoms of periodic AF.

How can N3-PUFAs prevent the acute symptoms of periodic AF? What is the role of vitamin D here?

It is debated if omega-3 polyunsaturated fatty acids may be effective in preventing AF (atrial fibrillation), meta-analysis here.

However, much less has been considered this: Do N3-PUFAs prevent acute symptoms of periodic Atrial fibrillation?

The meta-analysis concentrate only in the long-term effects of prevention. My proposal focuses on the short-term i.e. the fact that the user can recognise AF first and then uses N3-PUFAs.

Please, assume that there is a validation method by which the user can easily detect that he has AF - he does this if he suspect it i.e. feels special discomfort and special wave-like-pain the chest. He takes each time in this case 20 ml of Müller omega-3 oil which has also vitamin D. The effect of recovering is immediate in prophylaxis. Assume the user has less than < 20 ng/ml vitamin D in blood each case, most of the time, 9 ng/ml so avitaminosis.

My conjuncture is that N3-PUFAs can prevent the acute symptoms of periodic AF.

How can N3-PUFAs prevent the acute symptoms of periodic AF? What is the role of vitamin D here?

It is debated if omega-3 polyunsaturated fatty acids (N3PUFa) may be effective in preventing AF (atrial fibrillation), meta-analysis here.

However, much less has been considered this: Do N3-PUFAs prevent acute symptoms of periodic Atrial fibrillation?

The meta-analysis concentrate only in the long-term effects of prevention. My proposal focuses on the short-term i.e. the fact that the user can recognise AF first and then uses N3-PUFAs.

Please, assume that there is a validation method by which the user can easily detect that he has AF - he does this if he suspect it, i.e. feels special discomfort and special wave-like-pain the chest.

He takes each time in this case 20 ml of Müller omega-3 oil which has also vitamin D. The effect of recovering is immediate in prophylaxis. Assume the user has less than < 20 ng/ml vitamin D in blood each case, most of the time, 9 ng/ml so avitaminosis.

My conjuncture is that N3-PUFAs can prevent the acute symptoms of periodic AF.

How can N3-PUFAs prevent the acute symptoms of periodic AF? What is the role of vitamin D here?